• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

FDA-TRACK

The list below provides information on FDA’s performance measures and projects as aligned to FDA strategic priorities and program offices. This list enables you to view charts of performance data and progress on important projects and programs.

To view completed FDA-TRACK performance measures and projects view the Archive Index

Filter








Results

Number of results: 67

ItemProgramOfficeStrategic PlanStrategic Goal/Area
1Sample Feedback ReportsORAOffice of Associate Commissioner for Regulatory AffairsN/AN/A
2Efficiency of Foreign Trip PlanningORAOffice of Associate Commissioner for Regulatory AffairsN/AN/A
3ORA Quality Audit ProgramORAOffice of Associate Commissioner for Regulatory AffairsN/AAchieving Excellence
4Deploy MARCS Integrator Contract (MIC) ElementsORAOffice of Associate Commissioner for Regulatory AffairsN/AAnalyzing and Utilizing
5Deliver PREDICT ComponentsORAOffice of Associate Commissioner for Regulatory AffairsN/AAnalyzing and Utilizing
6Cumulative number of convictions and money recovered at the end of the quarterORAOffice of Criminal InvestigationsN/AAdvancing Public Health
7Number of cargo thefts resulting in public notifications in the month and notifications posted on OCI website within 24 hoursORAOffice of Criminal InvestigationsN/AN/A
8Suspected criminal activity reported through OCI web pageORAOffice of Criminal InvestigationsN/AN/A
9Cases initiated by OCI based on information originated/referred by District Offices/Centers in the monthORAOffice of Criminal InvestigationsN/AN/A
10Number of cases referred to Office of Enforcement by debarment actionORAOffice of Criminal InvestigationsN/AN/A
11Number of educational outreach meetings with Centers, Office of Regulatory Affairs, and District Offices in the monthORAOffice of Criminal InvestigationsN/AN/A
12Number of ORA District Conferences attended by OCI in the monthORAOffice of Criminal InvestigationsN/AN/A
13Number of senior management meetings with Centers in the monthORAOffice of Criminal InvestigationsN/AN/A
14Development of OCI's International Investigative UnitORAOffice of Criminal InvestigationsN/ALeveraging and Collaborating
15Office of Criminal Investigations (OCI) Education ProjectORAOffice of Criminal InvestigationsN/AN/A
16Percent of Class 1 Recall final press releases approved by OE for posting to the FDA.gov website within 24 hours of receiptORAOffice of EnforcementN/AN/A
17Number of OE-recommended and posted health fraud internet site warning lettersORAOffice of EnforcementN/AN/A
18Number and percent of debarment referrals OE received and recommendedORAOffice of EnforcementN/AN/A
19Recall related press releases and alerts submittedORAOffice of EnforcementN/AN/A
20Percentage of ORA employees supporting and trained in the Quality Management System (QMS) to improve ORA operational effectivenessORAN/AN/AN/A
21Automated Enforcement Report ProjectORAOffice of EnforcementN/AN/A
22Follow Up Inspection Effectiveness ProjectsORAOffice of EnforcementN/AN/A
23Number of foreign inspections completed in the monthORAOffice of OperationsN/AAdvancing Public Health
24FDA Foreign Inspections by Product TypeORAOffice of OperationsN/AAdvancing Public Health
25Number of foreign inspections completed in the month resulting in an initial classification of No Action IndicatedORAOffice of Regional OperationsN/AN/A
26Number of foreign inspections completed in the month resulting in an initial classification of Voluntary Action IndicatedORAOffice of Regional OperationsN/AN/A
27Number of foreign inspections completed in the month resulting in an initial classification of Official Action IndicatedORAOffice of Regional OperationsN/AN/A
28Number of foreign inspections completed in the month resulting in a category of classifications called OTHERORAOffice of Regional OperationsN/AN/A
29Number of foreign inspections completed at the end of the monthORAOffice of Regional OperationsN/AN/A
30Use of portable scientific applications to assist in regulatory decisions earlier in the supply chainORAOffice of Regional OperationsN/AAnalyzing and Utilizing
31Total and cumulative number of domestic inspectionsORARegional OfficesN/AAdvancing Public Health
32Number of domestic inspections in the quarter resulting in a classification of Official Action IndicatedORARegional OfficesN/AAdvancing Public Health
33Number of domestic inspections in the quarter resulting in a classification of Voluntary Action IndicatedORARegional OfficesN/AAdvancing Public Health
34Number of domestic inspections in the quarter resulting in a classification of No Action IndicatedORARegional OfficesN/AAdvancing Public Health
35Number of product domestic inspections in the quarter resulting in a category of classifications called OTHERORARegional OfficesN/AAdvancing Public Health
36Further develop a national integrated food safety system through the adoption of increased participation in the Voluntary Retail Food Program StandardORARegional OfficesN/ALeveraging and Collaborating
37Total and cumulative number of highest risk domestic inspectionsORARegional OfficesN/AN/A
38Number of highest risk domestic inspections in the quarter resulting in a classification of No Action IndicatedORARegional OfficesN/AN/A
39Number of highest risk domestic inspections in the quarter resulting in a classification of Official Action IndicatedORARegional OfficesN/AN/A
40Number of highest risk product domestic inspections in the quarter resulting in a category of classifications called OTHERORARegional OfficesN/AN/A
41Number of highest risk domestic inspections in the quarter resulting in a classification of Voluntary Action IndicatedORARegional OfficesN/AN/A
42Improve and standardize the Consumer Complaint ProcessORARegional OfficesN/AN/A
43Central Region - Improve response, follow up time and resolution of consumer complaintsORARegional Field Office, Central Region, Philadelphia, PAN/AN/A
44Northeast Region - Improve response, follow up time and resolution of consumer complaintsORARegional Field Office, Northeast Region, Jamaica, NYN/AN/A
45Pacific Region - Improve response, follow up time and resolution of consumer complaintsORARegional Field Office, Pacific Region, Oakland, CAN/AN/A
46Southeast Region - Improve response, follow up time and resolution of consumer complaintsORARegional Field Office, Southeast Region, Atlanta, GAN/AN/A
47Southwest Region - Improve response, follow up time and resolution of consumer complaintsORARegional Field Office, Southwest Region, Dallas, TXN/AN/A
48Total number of training events in the monthORAOffice of Resource ManagementN/AN/A
49Total number of employees who completed training events in the monthORAOffice of Resource ManagementN/AN/A
50Total number of Instructor-led training events for FDA employees in the monthORAOffice of Resource ManagementN/AN/A
51Total number of FDA employees who completed Instructor-led training events in the monthORAOffice of Resource ManagementN/AN/A
52Total number of Instructor-led training events for State, Local, Territorial, and Tribal Partners in the monthORAOffice of Resource ManagementN/AN/A
53Total Number of Instructor-led training events completed by State, Local, Territorial, Tribal Partners in the monthORAOffice of Resource ManagementN/AN/A
54Total number of online training events in the monthORAOffice of Resource ManagementN/AN/A
55Total number of employees who completed the online training events in the monthORAOffice of Resource ManagementN/AN/A
56Number of FDA/ORA investigators, analysts and managers completing courses in specific subject matter in a monthORAOffice of Resource ManagementN/AN/A
57Number of certificates earned by State/Local/Territorial/Tribal regulatory officials in specific subject matter in a monthORAOffice of Resource ManagementN/AN/A
58Number of web-based training modules/courses completed by FDA employees and Partners in a monthORAOffice of Resource ManagementN/AN/A
59Number of external presentations to societies, consortia, industry and government organizations in the monthORAOffice of OperationsN/ALeveraging and Collaborating
60Total number of samples received and analyses performed in the monthORAORA LabsN/AN/A
61Domestic food samples received and analyzed in the monthORAORA LabsN/AN/A
62Import food samples received and analyzed in the monthORAORA LabsN/AN/A
63Domestic animal feed samples received and analyzed in the monthORAORA LabsN/AN/A
64Import animal feed samples received and analyzed in the monthORAORA LabsN/AN/A
65Import human drug samples received and analyzed in the monthORAORA LabsN/AN/A
66Import device/radiological health samples received and analyzed in the monthORAORA LabsN/AN/A
67Total number of samples found to be violative and forwarded for review and regulatory follow-up in the monthORAORA LabsN/AN/A

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information in the Archive Index may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.